June 23-24 OneMedForum New York

OneMedPlace Trans-Atlantic Conference on June 23rd-24th is a gathering of fast growing, emerging healthcare and life science companies in Europe […]

Read more »

Is Europe A Better Place To Build A Medical Technology Company? (Video)

Growth in the life sciences industries will greatly depend on how the FDA responds to growing complaints that they are stifling medical technologies.

Read more »

Killing Canine Cancer:Functional Nutriments Applies Ground-Breaking Therapy To Human Patients (Video)

Cancer, a word that strikes a chord of fear in many, is a fighting word. At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry, and while it is a match we have yet to win, researchers and scientists have on their boxing gloves and are staying in the fight.

Read more »

A Heart To Heart Talk On The Future Of Cardiology (Video)

According to the American Heart Association, more than 13 million people suffer from coronary heart disease, 6 million from angina, and 7 million from myocardial infraction. Rapid technological advances and product innovation are transforming the cardiology market.

Read more »

OneMedPlace Brings 17 Diverse Workshop Sessions With New Inspirations To All Involved

This year at OneMedForum San Francisco, OneMedPlace offered 17 workshop sessions on a variety of subjects helping investors grow their businesses.

Read more »

Advanced Life Sciences Announces Two New Achievements

Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.

Read more »

GE Healthcare to Acquire Diagnostics Company Clarient

General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.

Read more »

A New Treatment for Macular Degeneration

If you are interested in learning more about this company or technology complete the form below. First*: Last*: Company / […]

Read more »

Ischemic Stroke: Challenging Market, Huge Need

Time is critical when a patient suffers from a stroke.

Read more »

Advanced Life Sciences: Addressing Antibiotic Resistance in Infectious Disease Market

The company’s lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.

Read more »